Results 31 to 40 of about 846,523 (399)

COVID‐19, nausea, and vomiting

open access: yesJournal of Gastroenterology and Hepatology, 2020
Exclusion of nausea (N) and vomiting (V) from detailed consideration as symptoms of COVID‐19 is surprising as N can be an early presenting symptom. We examined the incidence of NV during infection before defining potential mechanisms.
P. Andrews   +3 more
semanticscholar   +1 more source

A study on utilization and evaluation of antiemetics in chemotherapy-induced nausea and vomiting

open access: yesIndian Journal of Medical and Paediatric Oncology, 2017
Purpose: Chemotherapy-induced nausea and vomiting (CINV) are the major adverse effects of cancer chemotherapy. The objectives of this study are to evaluate the utilization of antiemetics in CINV and to assess the emetogenicity of chemotherapy and to ...
Gayathri Baburaj   +6 more
doaj   +1 more source

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. [PDF]

open access: yes, 2011
Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and ...
Baak-Pablo, Renee F   +8 more
core   +2 more sources

Anticipatory nausea and vomiting [PDF]

open access: yesSupportive Care in Cancer, 2004
Anticipatory nausea and vomiting (ANV) is not only a learned response but can occur without prior exposure to chemotherapy depending on patient emotional distress and expectations. The best method to avoid development or reinforcement of ANV is to avoid both vomiting and nausea from the first exposure to chemotherapy.
Aapro, M., Molassiotis, A., Olver, I.
openaire   +5 more sources

Evaluation of Transdermal Formulations of Metoclopramide Prepared Using Arachis Oil and Liquid Paraffin as Permeation Enhancers

open access: yesPharmaceutical and Biomedical Research, 2020
Background: The study aimed to evaluate the effect of arachis oil and liquid paraffin on metoclopramide release from transdermal films. Objectives: Batches of metoclopramide films were prepared with hydroxypropyl methyl cellulose (HPMC), arachis oil or ...
Sylvester O. Eraga   +2 more
doaj   +1 more source

Effects of Modification of Pain Protocol on Incidence of Post Operative Nausea and Vomiting. [PDF]

open access: yes, 2016
BackgroundA Perioperative Surgical Home (PSH) care model applies a standardized multidisciplinary approach to patient care using evidence-based medicine to modify and improve protocols.
Ahn, Kyle   +7 more
core   +2 more sources

Measurement of nausea [PDF]

open access: yesJournal of Pain and Symptom Management, 1989
Dr. Mary Barnes’ has written an excellent review on “nausea and vomiting in the patient with advanced cancer.” In addition to the pain suffered by the majority of cancer patients, nausea caused by chemotherapy, narcotics, or the disease process itself represents another torment to be endured by almost 50% of cancer patients.
openaire   +2 more sources

Cannabinoid Hyperemesis Syndrome [PDF]

open access: yes, 2015
Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent ...
Heise, Lynn
core   +2 more sources

The efficacy and safety of Xiao-Ban-Xia-Tang in the treatment of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis

open access: yesFrontiers in Pharmacology
BackgroundChemotherapy-induced nausea and vomiting (CINV) is one of the most frequent and critical side effects due to chemotherapeutics. In China, Xiao-Ban-Xia-Tang (XBXT) has already been applied extensively to prevent and treat CINV. However, there is
Ling Li   +4 more
doaj   +1 more source

Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis

open access: yesFrontiers in Oncology
BackgroundThe effectiveness of a dexamethasone-sparing strategy in the treatment of breast cancer with anthracycline-cyclophosphamide therapy when combined with first-generation 5-HT3 receptor antagonists (RAs) and neurokinin-1 RAs is unclear.
Daichi Watanabe   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy